FDA could hit homoeopathy market
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
The US Food and Drug Administration’s (FDA’s) draft guidance on OTC homeopathic products will confuse the industry, consumers and retailers and lead to the products being sold online only, according to the American Association of Homeopathy Pharmacists (AAHP).